background and objectives: pneumocystis jiroveci is an important causative agent of pneumocystis pneumonia. during childhood, exposure to pneumocystis occurs and antibody was built in early childhood. the aim of this study was to describe the molecular epidemiology of p. jiroveci in children without any respiratory syndrome and survey the distribution of different mitochondrial large subunit, r...

BACKGROUND Pneumocystis jiroveci (formerly known as P. carinii f.sp. hominis) is an opportunistic fungus that causes Pneumocystis pneumonia (PCP) in immunocompromised individuals. Pneumocystis jiroveci can be detected by polymerase chain reaction (PCR). To investigate the clinical importance of a positive Pneumocystis-PCR among HIV-uninfected patients suspected of bacterial pneumonia, a retrosp...

Pneumocystis jiroveci pneumonia (PCP) has long been recognized as a cause of mortality in immuno-compromised populations, including those with advanced lung cancer. Although Pneumocystis colonization has only recently been described due to the development of more sensitive molecular techniques, including polymerase chain reaction (PCR), it is unknown whether Pneumocystis colonization leads to t...

OBJECTIVE The purpose of this essay is to review the spectrum of high-resolution CT findings of Pneumocystis jiroveci pneumonia in immunocompromised patients with and without HIV infection. CONCLUSION Pneumocystis jiroveci pneumonia is a common opportunistic infection affecting immunosuppressed patients. High-resolution CT may be indicated for evaluation of immunosuppressed patients with susp...

The frequency of Pneumocystis jiroveci (human-derived Pneumocystis) in immunocompetent infants developing acute respiratory syndromes has recently been evaluated and has been shown to be close to 25%. Until now, there have been no data on the genomic characteristics of the fungus in these patients, while molecular typing of P. jiroveci organisms was mostly performed with samples from immunosupp...

Pulmonary colonization by the opportunistic pathogen Pneumocystis jiroveci is common in HIV(+) subjects and has been associated with development of chronic obstructive pulmonary disease (COPD). Host and environmental factors associated with colonization susceptibility are undefined. Using a simian-human immunodeficiency virus (SHIV) model of HIV infection, the immunologic parameters associated ...

conclusions in molecular epidemiology studies, nested pcr has higher sensitivity than pcr. results of this study support the colonization of p. jiroveci in patients receiving lung transplantation. patients who are carriers of p. jiroveci are at a higher risk of p. jiroveci pneumonia. results the genome of p. jiroveci was revealed by a 346 bp pcr product in the initial amplification and a 120 bp...

We report a case of HSV type 2 pneumonia in an HIV infected patient. The patient was empirically treated for severe Pneumocystis jiroveci community acquired pneumonia. Bronchoscopy with bronchoalveolar lavage was done, the cytology of which was negative for Pneumocystis jiroveci. All cultures were negative. HSV type 2 was isolated from BAL on culture. The patient died of pulmonary embolism. The...

Pneumocystis jiroveci is an important cause of mortality and morbidity among heart transplant recipients. This raises the question of prophylactic treatment for this infection. Trimethoprimsulfamethoxazole is commonly used in P. jiroveci pneumonia prophylaxis with mild to severe adverse effects. We present the use of inhaled pentamidine as P. jiroveci prophylaxis in a patient with an allergy to...

Pneumocystis jiroveci, formerly known as Pneumocystis carinii, is now believed to be a fungus. P. jiroveci pneumonia is a fungal infection, the primary symptoms of which include progressive dyspnea, nonproductive cough, and low-grade fever. These patients are often profoundly hypoxemic, and chest radiographs typically show bilateral, diffuse interstitial infiltrates. While P. jiroveci pneumonia...